C Chiappa1, F Rovera2, S Rausei2, S Del Ferraro2, A Fachinetti2, M Lavazza2, V Marchionini2, V Arlant2, M L Tanda3, E Piantanida3, H Y Kim4, A Anuwong5, G Dionigi2. 1. Senology Research Center - 1st Division of Surgery, Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy. corrado.doc@gmail.com. 2. Senology Research Center - 1st Division of Surgery, Department of Surgical and Morphological Sciences, University of Insubria, Varese, Italy. 3. Endocrine Unit, Ospedale di Circolo - University of Insubria, Varese, Italy. 4. KUMC Thyroid Center, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea. 5. Department of Surgery, Police General Hospital, Faculty of Medicine, Siam University, Pathumwan, Bangkok, Thailand.
Abstract
INTRODUCTION: The aim of this study was to evaluate the association of breast cancer with thyroid diseases. Many authors have already studied the possible relationship between these two diseases, but the results are nowadays conflicting. MATERIALS AND METHODS: Our study examining 867 patients with breast cancer (862 women and 5 men, average age = 61 years old) of whom 141 also had thyroid disease evaluated the recurrence of thyroid diseases and their association with different types of breast cancer. Statistical analyses were performed using SPSS software for Windows; we used nonparametric tests (Chi-square and Mann-Whitney), and the level of significance was set at p < 0.05. RESULTS: We found a significant association between breast cancer diagnosed after menopause and thyroid disease (p < 0.003). Moreover, we analyzed the role of thyroid autoimmunity identifying an association between chronic autoimmune thyroiditis and breast cancer diagnosed before menopause (p < 0.05). Regarding receptor profile of breast carcinoma, we have found an increased expression of estrogen receptors in patients with autoimmune thyroiditis compared to patients with any other thyroid diseases (p < 0.03). Contrariwise, we do not have found any difference between the group with every thyroid disease and the group without thyroid disease (p < 1.00). We did not find other statistically significant associations with breast cancer's parameters like family history, tumor size, lymph node metastasis, distant metastasis, cancer clinical and pathological stage, differentiation grade and expression of Ki67, p53 and Her2 in the two main groups with or without thyroid disease. Likewise, we did not found other statistically significant association between hypothyroidism or hyperthyroidism and breast cancer.
INTRODUCTION: The aim of this study was to evaluate the association of breast cancer with thyroid diseases. Many authors have already studied the possible relationship between these two diseases, but the results are nowadays conflicting. MATERIALS AND METHODS: Our study examining 867 patients with breast cancer (862 women and 5 men, average age = 61 years old) of whom 141 also had thyroid disease evaluated the recurrence of thyroid diseases and their association with different types of breast cancer. Statistical analyses were performed using SPSS software for Windows; we used nonparametric tests (Chi-square and Mann-Whitney), and the level of significance was set at p < 0.05. RESULTS: We found a significant association between breast cancer diagnosed after menopause and thyroid disease (p < 0.003). Moreover, we analyzed the role of thyroid autoimmunity identifying an association between chronic autoimmune thyroiditis and breast cancer diagnosed before menopause (p < 0.05). Regarding receptor profile of breast carcinoma, we have found an increased expression of estrogen receptors in patients with autoimmune thyroiditis compared to patients with any other thyroid diseases (p < 0.03). Contrariwise, we do not have found any difference between the group with every thyroid disease and the group without thyroid disease (p < 1.00). We did not find other statistically significant associations with breast cancer's parameters like family history, tumor size, lymph node metastasis, distant metastasis, cancer clinical and pathological stage, differentiation grade and expression of Ki67, p53 and Her2 in the two main groups with or without thyroid disease. Likewise, we did not found other statistically significant association between hypothyroidism or hyperthyroidism and breast cancer.
Entities:
Keywords:
Autoimmune thyroiditis; Breast cancer; Breast surgery; Breast treatment; Thyroid disease
Authors: E Giustarini; A Pinchera; P Fierabracci; M Roncella; L Fustaino; C Mammoli; C Giani Journal: Eur J Endocrinol Date: 2006-05 Impact factor: 6.664
Authors: Johannes L P Kuijpens; Ivan Nyklíctek; Marieke W J Louwman; Tony A P Weetman; Victor J M Pop; Jan-Willem W Coebergh Journal: Thyroid Date: 2005-11 Impact factor: 6.568
Authors: Luka Brčić; Ana Barić; Sanda Gračan; Vesela Torlak; Marko Brekalo; Veselin Škrabić; Tatijana Zemunik; Maja Barbalić; Ante Punda; Vesna Boraska Perica Journal: Sci Rep Date: 2019-03-29 Impact factor: 4.379